Results 181 to 190 of about 97,767 (354)
Title from acquisitions documentation, see file NLA12/324.; Part of the collection: The Australian Ballet in dress rehearsals for the 2007 Destiny season and 2009 Concord season, Melbourne.; Acquired in digital format; access copy available online ...
McFarlane, Jim, 1955-
core
Fluorescent BODIPY‐conjugated thiosemicarbazone ligands and their Ga(III), In(III), and Fe(III) complexes, inspired by Triapine, are developed as theranostic agents. Multiphoton FLIM and confocal microscopy in cancer cells and zebrafish reveal real‐time uptake, mitochondrial localisation, and whilst spectroscopic assays indicated preserved complex ...
Megan J. Green +15 more
wiley +1 more source
Title from acquisitions documentation, see file NLA12/324.; Part of the collection: The Australian Ballet in dress rehearsals for the 2007 Destiny season and 2009 Concord season, Melbourne.; Acquired in digital format; access copy available online ...
McFarlane, Jim, 1955-
core
Human‐relevant methods are essential for modern chemical safety assessment. This study helps define the capabilities and boundaries of an in vitro testing battery for developmental neurotoxicity by exploring its biological applicability domain. By linking neurodevelopmental disease‐related pathways to key neurodevelopmental processes, the work enhances
Eliska Kuchovska +14 more
wiley +1 more source
Repurposing HER2 IHC: Pan-HER2 and Low-HER2. [PDF]
Troxell ML.
europepmc +1 more source
Title from acquisitions documentation, see file NLA12/324.; Part of the collection: The Australian Ballet in dress rehearsals for the 2007 Destiny season and 2009 Concord season, Melbourne.; Acquired in digital format; access copy available online ...
McFarlane, Jim, 1955-
core
Molecular Glue cc‐885 Inhibits VHL‐Deficient Clear Cell Renal Cell Carcinoma via ETS1 Degradation
VHL‐deficient kidney cancer lacks effective treatments. This study reveals that the molecular glue degrader cc‐885 hijacks the cellular recycling system to selectively destroy the oncogenic protein ETS1, effectively killing VHL‐mutant tumors. Combining CC‐885 with the approved drug belzutifan achieves powerful synergy, offering a promising new ...
Taowei Yang +15 more
wiley +1 more source
Diazoxide choline extended-release (DCCR) use in Prader-Willi syndrome: patient selection, dosing, and management. [PDF]
Miller JM +3 more
europepmc +1 more source

